Sudarshan Pharma Industries Limited, a prominent player in the pharmaceutical sector, has successfully secured $20 million through the issuance of Foreign Currency Convertible Bonds (FCCBs). The company was expertly advised by Rajani Associates in this significant financial maneuver.
The advisory team at Rajani Associates was spearheaded by Sangeeta Lakhi, a Senior Partner with extensive experience in financial legalities. She was ably supported by a team of adept associates, including Sommya Khandelwal, Dipendra Singh Tomar, and Rishi Sharma.
Sudarshan Pharma, renowned for its manufacturing and trading capabilities, is actively involved in the production of specialty chemicals, agrochemicals, and paints. The company also extends its expertise by providing tailored specialty chemicals to a diverse range of clients both in India and internationally.
This move marks a significant step for Sudarshan Pharma, enhancing its financial strength and enabling it to further its reach in the global market. The successful raising of funds through FCCBs not only underscores the company’s robust financial strategies but also highlights Rajani Associates’ proficiency in steering complex financial transactions.
For more information or to have your Deals, Columns, or Press Releases featured on Bar & Bench, please complete the submission form available here.
